Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Retinoblastoma × Cytapheresis × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 1 Recurrence 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

Carboplatin 18 Etoposide 15 Vincristine 13 Melphalan 10 Filgrastim 10 Topotecan 8 Granulocyte Colony-Stimulating Factor 8 Cyclophosphamide 8 Thiotepa 6 Cryotherapy 5 Mesna 4 Peripheral Blood Stem Cell Transplantation 3 Drug Therapy 3 Doxorubicin 3 Busulfan 3 Temozolomide 2 Radiotherapy 2 Magnetic Resonance Imaging 2 Ifosfamide 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 omburtamab I-131 1 etoposide phosphate 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡